Halozyme Therapeutics Inc (HALO)
38.46
-0.66
(-1.69%)
USD |
NASDAQ |
Apr 25, 16:00
38.46
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Total Return Level: 38.46 for April 25, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 25, 2024 | 38.46 |
April 24, 2024 | 39.12 |
April 23, 2024 | 38.97 |
April 22, 2024 | 38.71 |
April 19, 2024 | 38.64 |
April 18, 2024 | 37.81 |
April 17, 2024 | 38.02 |
April 16, 2024 | 38.38 |
April 15, 2024 | 38.72 |
April 12, 2024 | 38.61 |
April 11, 2024 | 39.32 |
April 10, 2024 | 39.28 |
April 09, 2024 | 40.13 |
April 08, 2024 | 39.91 |
April 05, 2024 | 41.07 |
April 04, 2024 | 39.73 |
April 03, 2024 | 40.23 |
April 02, 2024 | 40.43 |
April 01, 2024 | 41.32 |
March 28, 2024 | 40.68 |
March 27, 2024 | 40.73 |
March 26, 2024 | 40.08 |
March 25, 2024 | 40.42 |
March 22, 2024 | 40.08 |
March 21, 2024 | 40.22 |
Date | Value |
---|---|
March 20, 2024 | 40.38 |
March 19, 2024 | 40.81 |
March 18, 2024 | 40.37 |
March 15, 2024 | 40.86 |
March 14, 2024 | 40.79 |
March 13, 2024 | 41.35 |
March 12, 2024 | 41.95 |
March 11, 2024 | 41.20 |
March 08, 2024 | 41.73 |
March 07, 2024 | 41.71 |
March 06, 2024 | 41.69 |
March 05, 2024 | 41.41 |
March 04, 2024 | 40.93 |
March 01, 2024 | 41.11 |
February 29, 2024 | 39.81 |
February 28, 2024 | 39.69 |
February 27, 2024 | 39.84 |
February 26, 2024 | 39.67 |
February 23, 2024 | 40.56 |
February 22, 2024 | 39.72 |
February 21, 2024 | 38.36 |
February 20, 2024 | 36.00 |
February 16, 2024 | 36.10 |
February 15, 2024 | 35.91 |
February 14, 2024 | 35.06 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
13.90
Minimum
Mar 18 2020
59.44
Maximum
Dec 02 2022
35.07
Average
38.19
Median
Oct 28 2021
Total Return Level Benchmarks
Johnson & Johnson | 471.47 |
Globus Medical Inc | 50.37 |
Denali Therapeutics Inc | 14.96 |
AIM ImmunoTech Inc | 0.43 |
Protalix BioTherapeutics Inc | 1.21 |